Institutional investors purchased a net $148.7 thousand shares of BIOC during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 8.90% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GARRISON, BRADFORD & ASSOCIATES,... Sold 3.0 Thousand shares of Biocept Inc
LMR PARTNERS LLP Sold 47.1 Thousand shares of Biocept Inc